TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
ESP Life Sciences Consulting AB
Closing information (x1000 DKK)
Closing information | 2024/01 | 2023/01 | 2022/01 |
Turnover |
623
|
509
|
712 |
Financial expenses |
38
|
0
|
4 |
Earnings before taxes |
132
|
195
|
433 |
EBITDA |
169
|
189
|
436 |
Total assets |
941
|
906
|
861 |
Current assets |
904
|
881
|
858 |
Current liabilities |
589
|
322
|
393 |
Equity capital |
342
|
575
|
458 |
- share capital |
33
![]() |
33
|
35 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2024/01 | 2023/01 | 2022/01 |
Solvency |
36.3%
|
63.5%
|
53.2% |
Turnover per employee |
623
|
509
|
712 |
Profit as a percentage of turnover |
21.2%
|
38.3%
|
60.8% |
Return on assets (ROA) |
18.1%
|
21.5%
|
50.8% |
Current ratio |
153.5%
|
273.6%
|
218.3% |
Return on equity (ROE) |
38.6%
|
33.9%
|
94.5% |
Change turnover |
113
|
-153
|
187 |
Change turnover % |
22%
|
-23%
|
36% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/01 | 2023/01 | 2022/01 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.